Andy Cowherd has over 25 years of investment banking and private equity investing experience focused on the healthcare sector. In these roles, he has completed a wide range of M&A and strategic advisory assignments, as well as numerous private and public financings, as both an advisor and principal.
Prior to joining England & Company in 2015, Mr. Cowherd was a Managing Director of Healthcare Investment Banking at Mesirow Financial. He also served as a Managing Director at Peter J. Solomon Company, Salomon Brothers, and BT Securities / Bankers Trust Co. In addition, Mr. Cowherd was a founding member and General Partner of Atlantic Medical Capital, LP, a private equity firm focused on the healthcare industry.
Mr. Cowherd earned his AB from Princeton University and his MBA from the Stanford University Graduate School of Business.
Richard NeJame is a senior investment banking executive with over 25 years of experience advising leveraged and distressed corporate clients, as well as institutional and other investing clients. His background includes capital raising, M&A, exchange offers, and Chapter 11 reorganizations. During his career, Mr. NeJame has executed more than $100 billion in aggregated transaction value involving over 80 deals.
Mr. NeJame started his career at Alex. Brown & Sons, where he became an integral part of the team that established the restructuring group at Lazard Frères & Co. He later led restructuring groups at Gleacher & Company and Oppenheimer & Co. Most recently, Mr. NeJame was a Senior Managing Director at B. Riley / FocalPoint prior to joining England & Company.
Mr. NeJame earned his BSE in Electrical Engineering from Duke University and received his MBA in Finance from the Wharton School of Business at the University of Pennsylvania.
Paul Teitelbaum has over 25 years of healthcare investment banking, corporate development, and management experience, with a particular focus on medical technology and life sciences. He has completed numerous M&A, financing, and strategic partnership transactions for private and public companies.
Prior to joining England & Company in 2015, Mr. Teitelbaum was Managing Director of the Healthcare Investment Banking Group at Mesirow Financial. He also served as a Managing Director of Healthcare Investment Banking at Landmark Ventures, and as a healthcare investment banker at Robertson Stephens and Burnham Securities. Previously, Mr. Teitelbaum held corporate development and disease management roles at Schering-Plough (now Merck & Co., Inc.) and Wyeth-Lederle (now Pfizer, Inc.).
Mr. Teitelbaum received his BA in Biology summa cum laude from the University of Pennsylvania and his MBA in Finance from the Wharton School of the University of Pennsylvania.
Craig MacKay has 30 years of investment banking experience focused on private financings for middle market companies. During his career, Mr. MacKay has been responsible for the issuance of over $9 billion of private equity, domestic and cross-border senior debt, high yield debt, and mezzanine securities. He has consummated dozens of acquisition financings, leveraged recapitalizations and refinancings across a broad spectrum of industries, including business services, communications/media, energy, financial services, healthcare, heavy industry, retail, technology, and transportation.
Prior to joining England & Company, Mr. MacKay headed the Private Finance Group at Oppenheimer & Company, where he led the origination and placement of private equity, debt, and structured securities. Prior to joining Oppenheimer (formerly CIBC World Markets), he was the head of Private Finance at SunTrust Robinson Humphrey, and was the Managing Member and founder of HNY Associates, an investment banking boutique. He began his career at Bankers Trust Company.
Mr. MacKay earned his BS in Economics and MBA in Finance at the Wharton School of the University of Pennsylvania and is a CFA Level 3 candidate. He has been active on numerous corporate and non-profit boards and currently serves as First Vice Chairman of the Federation of Protestant Welfare Agencies.
